Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1141 AL 1155

[Cell therapy for Parkinson's disease]

Morizane A, Takahashi J.

Nihon Yakurigaku Zasshi. 2016 May;147(5):264-8. doi: 10.1254/fpj.147.264.

Risk Factors for Malnutrition in Older Adults: A Systematic Review of the Literature Based on Longitudinal Data

Fávaro-Moreira NC, Krausch-Hofmann S, Matthys C, Vereecken C, Vanhauwaert E, Declercq A, Bekkering GE, Duyck J.

Adv Nutr. 2016 May 16;7(3):507-22. doi: 10.3945/an.115.011254. Print 2016 May.

Early-onset parkinsonism due to compound heterozygous POLG mutations

Rempe T, Kuhlenbäumer G, Krüger S, Biskup S, Matschke J, Hagel C, Deuschl G, van Eimeren T.

Parkinsonism Relat Disord. 2016 Aug;29:135-7. doi: 10.1016/j.parkreldis.2016.04.020. Epub 2016 Apr 27.

Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development

Jennum P, Christensen JA, Zoetmulder M.

Nat Sci Sleep. 2016 Apr 15;8:107-20. doi: 10.2147/NSS.S99240. eCollection 2016.

Translational Challenge Models in Support of Efficacy Studies: Neurobehavioral and Cognitive Changes Induced by Transcranial Magnetic Stimulation in Healthy Volunteers

Martin-Trias P, Bragulat V, Peña-Gómez C, Sala-Llonch R, Lanteaume L, Cassé-Perrot C, Blin O, Micallef J, Auffret A, Bartrés-Faz D.

CNS Neurol Disord Drug Targets. 2016;15(7):802-15. doi: 10.2174/1871527315666160518124316.

Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology

Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M.

Brain. 2016 May;139(Pt 5):1325-47. doi: 10.1093/brain/aww050.

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study

Masellis M, Collinson S, Freeman N, Tampakeras M, Levy J, Tchelet A, Eyal E, Berkovich E, Eliaz RE, Abler V, Grossman I, Fitzer-Attas C, Tiwari A, Hayden MR, Kennedy JL, Lang AE, Knight J; ADAGIO investigators.

Brain. 2016 Jul;139(Pt 7):2050-62. doi: 10.1093/brain/aww109. Epub 2016 May 13.

Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials

Huot P, Fox SH, Brotchie JM.

J Pharmacol Exp Ther. 2016 Jun;357(3):562-9. doi: 10.1124/jpet.116.232371. Epub 2016 Apr 13.

Histamine and Immune Biomarkers in CNS Disorders

Cacabelos R, Torrellas C, Fernández-Novoa L, López-Muñoz F.

Mediators Inflamm. 2016;2016:1924603. doi: 10.1155/2016/1924603. Epub 2016 Apr 13.

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease

Hanganu A, Monchi O.

Parkinsons Dis. 2016;2016:3217960. doi: 10.1155/2016/3217960. Epub 2016 Apr 14.

[Cognitive Training in Parkinson's Disease - A New Therapy Option?]

Kalbe E, Folkerts AK.

Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S24-35. doi: 10.1055/s-0042-100724. Epub 2016 May 18.

Pathological Effects of the FMR1 CGG-Repeat Polymorphism (5-55 Repeat Numbers): Systematic Review and Meta-Analysis

Yang W, Fan C, Chen L, Cui Z, Bai Y, Lan F.

Tohoku J Exp Med. 2016 May;239(1):57-66. doi: 10.1620/tjem.239.57.

Early synaptic dysfunction in Parkinson's disease: Insights from animal models

Schirinzi T, Madeo G, Martella G, Maltese M, Picconi B, Calabresi P, Pisani A.

Mov Disord. 2016 Jun;31(6):802-13. doi: 10.1002/mds.26620. Epub 2016 May 19.

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P.

Mov Disord. 2016 Oct;31(10):1455-1465. doi: 10.1002/mds.26649.

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC.

Mov Disord. 2016 Jun;31(6):861-81. doi: 10.1002/mds.26662. Epub 2016 May 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias